← Leaderboards
Jakub Tolar
University Of Minnesota
$8,610,650
Attributed
$10,058,626
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,058,626 · 8
By mechanism
R01$5,924,370 · 2
P01$2,867,037 · 2
R21$838,750 · 2
R43$376,083 · 1
T32$52,386 · 1
Top collaborators
- Dennis Roop5 shared
- Frank Wolfgang Albert2 shared
- Daniel Fred Carlson1 shared
- Karen Echeverri1 shared
- Mark J Osborn1 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Kacey Linnea Guenther Bui$128,503
- Beau Richard Webber$2,853,539
- Mark J Osborn$748,457
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsStem CellsPre-ClinicalGenesBaseImmuneToxic EffectInduced Pluripotent Stem CellCell TherapyResponseTechnologyMouse ModelMediatingSafetySourceFutureGene CorrectionDesignAutologousClinical TrialsProteinsGenomeNucleaseMutation
Grant awards (33)
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa$329,375
R01 · FY2025 · AR · contact PI
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa$330,770
R01 · FY2024 · AR · contact PI
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa$341,000
R01 · FY2023 · AR · contact PI
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa$337,590
R01 · FY2022 · AR · contact PI
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa$330,770
R01 · FY2021 · AR · contact PI
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa$339,167
R01 · FY2020 · AR · contact PI
In Vivo Murine Models Core$237,517
P01 · FY2019 · CA · contact PI
Genetic mapping of cellular trait variation in single human individuals$192,500
R21 · FY2019 · HG
In Vivo Murine Models Core$244,863
P01 · FY2018 · CA · contact PI
Genetic mapping of cellular trait variation in single human individuals$231,000
R21 · FY2018 · HG
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa$435,018
R01 · FY2017 · AR · contact PI
In Vivo Murine Models Core$244,863
P01 · FY2017 · CA · contact PI
Stem Cell Biology Training Program$52,386
T32 · FY2017 · GM
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa$435,018
R01 · FY2016 · AR · contact PI
Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases$345,938
R01 · FY2016 · AR
In Vivo Murine Models Core$244,863
P01 · FY2016 · CA · contact PI
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa$435,018
R01 · FY2015 · AR · contact PI
Development and maintenance of T, B and NK-cell deficient swine by multiplex gene-editing and immune restoration$376,083
R43 · FY2015 · HL
Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases$345,938
R01 · FY2015 · AR
In Vivo Murine Models Core$246,579
P01 · FY2015 · CA · contact PI
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa$437,074
R01 · FY2014 · AR · contact PI
Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases$338,558
R01 · FY2014 · AR
Human Adoptive Transfer Core$334,331
P01 · FY2014 · CA · contact PI
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa$458,962
R01 · FY2013 · AR · contact PI
Human Adoptive Transfer Core$359,697
P01 · FY2013 · CA · contact PI
Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases$327,661
R01 · FY2013 · AR
Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases$356,513
R01 · FY2012 · AR
Human Adoptive Transfer Core$347,714
P01 · FY2012 · CA · contact PI
Human Adoptive Transfer Core$9,295
P01 · FY2012 · CA · contact PI
Human Adoptive Transfer Core$346,948
P01 · FY2011 · CA · contact PI
Human Adoptive Transfer Core$250,367
P01 · FY2010 · CA · contact PI
Hematopoietic Stem Cell Transposon Therapy for Severe Combined Immunodeficiency$226,500
R21 · FY2009 · AI · contact PI
Hematopoietic Stem Cell Transposon Therapy for Severe Combined Immunodeficiency$188,750
R21 · FY2008 · AI · contact PI